Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model

Molecular Therapy

Volumn 20, Issue 5, 2012, Pages 908-917

  Vets, Sofie ^a   Kimpel, Janine ^b,c   Volk, Andreas ^b   De Rijck, Jan ^a   Schrijvers, Rik ^a   Verbinnen, Bert ^a,d   Maes, Wim ^a   Von Laer, Dorothee ^c   Debyser, Zeger ^a   Gijsbers, Rik ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d Experimental Laboratory Immunology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; LENS EPITHELIUM DERIVED GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL BASED GENE THERAPY; CELL KILLING; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; VIRUS LOAD; VIRUS REPLICATION;

MUS;

EID: 84860524273     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.6     Document Type: Article

References (49)

1. Van Maele, B, Busschots, K, Vandekerckhove, L, Christ, F and Debyser, Z (2006). Cellular co-factors of HIV-1 integration. Trends Biochem Sci 31: 98-105. (Pubitemid 43221842)
2. Spearman, P (2006). Cellular cofactors involved in HIV assembly and budding. Curr Opin HIV AIDS 1: 200-207.
3. Cherepanov, P, Maertens, G, Proost, P, Devreese, B, Van Beeumen, J, Engelborghs, Y et al. (2003). HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278: 372-381. (Pubitemid 36043586)
4. Llano, M, Morrison, J and Poeschla, EM (2009). Virological and cellular roles of the transcriptional coactivator LEDGF/p75. Curr Top Microbiol Immunol 339: 125-146.
5. Hendrix, J, Gijsbers, R, De Rijck, J, Voet, A, Hotta, J, McNeely, M et al. (2011). The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering. Nucleic Acids Res 39: 1310-1325.
6. Turlure, F, Maertens, G, Rahman, S, Cherepanov, P and Engelman, A (2006). A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res 34: 1653-1665.
7. Cherepanov, P, Ambrosio, AL, Rahman, S, Ellenberger, T and Engelman, A (2005). Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc Natl Acad Sci USA 102: 17308-17313. (Pubitemid 41740862)
8. McKee, CJ, Kessl, JJ, Shkriabai, N, Dar, MJ, Engelman, A and Kvaratskhelia, M (2008). Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J Biol Chem 283: 31802-31812.
9. McNeely, M, Hendrix, J, Busschots, K, Boons, E, Deleersnijder, A, Gerard, M et al. (2011). In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75. J Mol Biol 410: 811-830.
10. Gijsbers, R, Ronen, K, Vets, S, Malani, N, De Rijck, J, McNeely, M et al. (2010). LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther 18: 552-560.
11. Ferris, AL, Wu, X, Hughes, CM, Stewart, C, Smith, SJ, Milne, TA et al. (2010). Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proc Natl Acad Sci USA 107: 3135-3140.
12. Christ, F, Voet, A, Marchand, A, Nicolet, S, Desimmie, BA, Marchand, D et al. (2010). Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Nat Chem Biol 6: 442-448.
13. Kitchen, SG, Shimizu, S and An, DS (2011). Stem cell-based anti-HIV gene therapy. Virology 411: 260-272.
14. von Laer, D, Baum, C and Protzer, U (2009). Antiviral gene therapy. Handb Exp Pharmacol :265-297.
15. Neagu, MR, Ziegler, P, Pertel, T, Strambio-De-Castillia, C, Grütter, C, Martinetti, G et al. (2009). Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Invest 119: 3035-3047.
16. Fehse, B, Richters, A, Putimtseva-Scharf, K, Klump, H, Li, Z, Ostertag, W et al. (2000). CD34 splice variant: an attractive marker for selection of gene-modified cells. Mol Ther 1(5 Pt 1): 448-456.
17. Cherepanov, P, Sun, ZY, Rahman, S, Maertens, G, Wagner, G and Engelman, A (2005). Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat Struct Mol Biol 12: 526-532. (Pubitemid 43085883)
18. Llano, M, Saenz, DT, Meehan, A, Wongthida, P, Peretz, M, Walker, WH et al. (2006). An essential role for LEDGF/p75 in HIV integration. Science 314: 461-464. (Pubitemid 44628966)
19. Lusso, P, Cocchi, F, Balotta, C, Markham, PD, Louie, A, Farci, P et al. (1995). Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J Virol 69: 3712-3720.
20. Jaffee, BD and Claman, HN (1983). Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol 77: 1-12. (Pubitemid 13135593)
21. Meehan, AM, Saenz, DT, Morrison, J, Hu, C, Peretz, M and Poeschla, EM (2011). LEDGF dominant interference proteins demonstrate prenuclear exposure of HIV-1 integrase and synergize with LEDGF depletion to destroy viral infectivity. J Virol 85: 3570-3583.
22. Vandekerckhove, L, Christ, F, Van Maele, B, De Rijck, J, Gijsbers, R, Van den Haute, C et al. (2006). Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J Virol 80: 1886-1896. (Pubitemid 43228728)
23. Zielske, SP and Stevenson, M (2006). Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J Virol 80: 7275-7280. (Pubitemid 44025225)
24. Hütter, G, Nowak, D, Mossner, M, Ganepola, S, Müssig, A, Allers, K et al. (2009). Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360: 692-698.
25. Allers, K, Hütter, G, Hofmann, J, Loddenkemper, C, Rieger, K, Thiel, E et al. (2011). Evidence for the cure of HIV infection by CCR532/32 stem cell transplantation. Blood 117: 2791-2799.
26. Cannon, P and June, C (2011). Chemokine receptor 5 knockout strategies. Curr Opin HIV AIDS 6: 74-79.
27. Boden, D, Pusch, O and Ramratnam, B (2007). Overcoming HIV-1 resistance to RNA interference. Front Biosci 12: 3104-3116.
28. Pattanayak, V, Ramirez, CL, Joung, JK and Liu, DR (2011). Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 8: 765-770.
29. Taylor, BM, Foulke, JS, Flinko, R, Heredia, A, DeVico, A and Reitz, M (2008). An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence. J Virol 82: 5460-5471. (Pubitemid 351705253)
30. Glass, WG, McDermott, DH, Lim, JK, Lekhong, S, Yu, SF, Frank, WA et al. (2006). CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203: 35-40. (Pubitemid 43139642)
31. Liu, R, Paxton, WA, Choe, S, Ceradini, D, Martin, SR, Horuk, R et al. (1996). Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 86: 367-377. (Pubitemid 26272077)
32. Mummidi, S, Ahuja, SS, Gonzalez, E, Anderson, SA, Santiago, EN, Stephan, KT et al. (1998). Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 4: 786-793. (Pubitemid 28331019)
33. Wilen, CB, Wang, J, Tilton, JC, Miller, JC, Kim, KA, Rebar, EJ et al. (2011). Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases. PLoS Pathog 7: e1002020.
34. Hombrouck, A, De Rijck, J, Hendrix, J, Vandekerckhove, L, Voet, A, De Maeyer, M et al. (2007). Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog 3: e47.
35. Hare, S, Shun, MC, Gupta, SS, Valkov, E, Engelman, A and Cherepanov, P (2009). A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75. PLoS Pathog 5: e1000259.
36. Busschots, K, Vercammen, J, Emiliani, S, Benarous, R, Engelborghs, Y, Christ, F et al. (2005). The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J Biol Chem 280: 17841-17847. (Pubitemid 41389024)
37. Levine, BL, Bernstein, WB, Aronson, NE, Schlienger, K, Cotte, J, Perfetto, S et al. (2002). Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat Med 8: 47-53. (Pubitemid 34101728)
38. Perez, EE, Wang, J, Miller, JC, Jouvenot, Y, Kim, KA, Liu, O et al. (2008). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816. (Pubitemid 351961450)
39. Bartholomeeusen, K, De Rijck, J, Busschots, K, Desender, L, Gijsbers, R, Emiliani, S et al. (2007). Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. J Mol Biol 372: 407-421. (Pubitemid 47267963)
40. Bartholomeeusen, K, Christ, F, Hendrix, J, Rain, JC, Emiliani, S, Benarous, R et al. (2009). Lens epithelium-derived growth factor/p75 interacts with the transposasederived DDE domain of PogZ. J Biol Chem 284: 11467-11477.
41. Yokoyama, A and Cleary, ML (2008). Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14: 36-46. (Pubitemid 351885493)
42. Hughes, S, Jenkins, V, Dar, MJ, Engelman, A and Cherepanov, P (2010). Transcriptional co-activator LEDGF interacts with Cdc7-activator of S-phase kinase (ASK) and stimulates its enzymatic activity. J Biol Chem 285: 541-554.
43. DiGiusto, DL, Krishnan, A, Li, L, Li, H, Li, S, Rao, A et al. (2010). RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2: 36ra43.
44. De Rijck, J, Vandekerckhove, L, Gijsbers, R, Hombrouck, A, Hendrix, J, Vercammen, J et al. (2006). Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J Virol 80: 11498-11509. (Pubitemid 44788865)
45. Geraerts, M, Michiels, M, Baekelandt, V, Debyser, Z and Gijsbers, R (2005). Upscaling of lentiviral vector production by tangential flow filtration. J Gene Med 7: 1299-1310. (Pubitemid 41555436)
46. Adachi, A, Gendelman, HE, Koenig, S, Folks, T, Willey, R, Rabson, A et al. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291. (Pubitemid 16013975)
47. Spire, B, Sire, J, Zachar, V, Rey, F, Barré-Sinoussi, F, Galibert, F et al. (1989). Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene 81: 275-284. (Pubitemid 19231575)
48. Clavel, F, Guyader, M, Guétard, D, Sallé, M, Montagnier, L and Alizon, M (1986). Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature 324: 691-695. (Pubitemid 17206364)
49. Klaritsch, P, Mayer, S, Sbragia, L, Toelen, J, Roubliova, X, Lewi, P et al. (2010). Albumin as an adjunct to tracheal occlusion in fetal rats with congenital diaphragmatic hernia: a placebo-controlled study. Am J Obstet Gynecol 202: 198.e1-198.e9.